Free Trial

DENTSPLY SIRONA (XRAY) Expected to Announce Earnings on Thursday

DENTSPLY SIRONA logo with Medical background

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) is projected to release its Q1 2025 earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $0.30 per share and revenue of $854.75 million for the quarter.

DENTSPLY SIRONA Trading Down 3.4 %

XRAY traded down $0.47 during midday trading on Tuesday, reaching $13.37. 3,401,735 shares of the company were exchanged, compared to its average volume of 2,954,759. The stock has a market capitalization of $2.66 billion, a P/E ratio of -6.46, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA has a one year low of $12.16 and a one year high of $29.13. The stock's 50-day simple moving average is $14.42 and its 200 day simple moving average is $17.77. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.79%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.52% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several analyst reports. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Barrington Research dropped their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Finally, Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Thirteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA has an average rating of "Hold" and an average price target of $21.25.

Get Our Latest Analysis on DENTSPLY SIRONA

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines